217 W. MAIN STREET, SOMERVILLE, NJ
Pablo Guzman Resigns as Chief Medical Officer of ZyVersa Therapeutics
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News
News, Securities Holder Rights or Indentures, Material Contracts
News, Material Contracts
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023 amended
FY 2023
Effectiveness Notice
Amended Registration Statement for Securities
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notification Filed by a National Security Exchange
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload